FDA campaign H-0685-2026
Class IIHazard
Product contains undeclared Yellow No. 5.
Distribution
Nationwide. Outside the US to Australia, New Zealand, Singapore, and Trinidad and Tobago
REKALLD area-alert coverage: nationwide (our reading of the distribution above)
The text above is quoted verbatim from the FDA record. Confirm the affected units and the remedy with the manufacturer or FDA. Recall data may be incomplete, delayed, or superseded.